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Abstract
Background: The nuclear orphan receptor Nur77 (NR4A1, TR3, or NGFI-B) has been shown to modulate the
inflammatory response of macrophages. To further elucidate the role of Nur77 in macrophage physiology,
we compared the transcriptome of bone marrow-derived macrophages (BMM) from wild-type (WT) and Nur77-
knockout (KO) mice.
Results: In line with previous observations, SDF-1α (CXCL12) was among the most upregulated genes in
Nur77-deficient BMM and we demonstrated that Nur77 binds directly to the SDF-1α promoter, resulting in
inhibition of SDF-1α expression. The cytokine receptor CX3CR1 was strongly downregulated in Nur77-KO
BMM, implying involvement of Nur77 in macrophage tolerance. Ingenuity pathway analyses (IPA) to identify
canonical pathways regulation and gene set enrichment analyses (GSEA) revealed a potential role for Nur77
in extracellular matrix homeostasis. Nur77-deficiency increased the collagen content of macrophage extracellular matrix
through enhanced expression of several collagen subtypes and diminished matrix metalloproteinase (MMP)-9 activity. IPA
upstream regulator analyses discerned the small GTPase Rac1 as a novel regulator of Nur77-mediated gene expression.
We identified an inhibitory feedback loop with increased Rac1 activity in Nur77-KO BMM, which may explain the
augmented phagocytic activity of these cells. Finally, we predict multiple chronic inflammatory diseases to be
influenced by macrophage Nur77 expression. GSEA and IPA associated Nur77 to osteoarthritis, chronic obstructive
pulmonary disease, rheumatoid arthritis, psoriasis, and allergic airway inflammatory diseases.
Conclusions: Altogether these data identify Nur77 as a modulator of macrophage function and an interesting
target to treat chronic inflammatory disease.
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Background
Nuclear receptor Nur77, also known as NR4A1, TR3 or
NGFI-B, is a member of the NR4A receptor subfamily
that also comprises Nurr1 (NR4A2, NOT) and NOR-1
(NR4A3, MINOR). Like other nuclear receptors, the
NR4As consist of an N-terminal transactivation domain,
a central zinc finger DNA binding domain (~94 %
homology within the subfamily) and a C-terminal ligand
binding domain. Structural analyses revealed that the
NR4A receptors lack a classical hydrophobic ligand-
binding pocket as a result of hydrophobic residues of
amino-acid side chains, and so far no ligands have been
identified [1, 2]. Nur77 is therefore referred to as an or-
phan nuclear receptor and its activity is regulated
through gene expression, posttranslational modifications
and coregulator interactions, as recently reviewed [3].
Nur77 is a typical early response gene and its induction
can be achieved with a plethora of stimuli among which
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peptide hormones, mitogens, physical stimulation and
inflammatory factors. Known transcription factors indu-
cing its expression include cyclic adenosine monopho-
sphate (cAMP) responsive element binding protein
(CREB), activator protein 1 (AP-1), NFκB, and myocyte
enhancer factor 2 (MEF2). Nur77 can bind as a mono-
mer to the so-called NGFI-B response element (NBRE;
AAAGGCTA) in the promoter region of direct target
genes. Nur77 and Nurr1 can also form homodimers and
heterodimers with retinoid X receptor and bind a DR-5
response element [4]. Furthermore, gene transcription is
modulated by Nur77 itself through transrepression of
other transcription factors. For example, Nur77 exhibits
a direct, inhibitory interaction with the p65 subunit of
NFκB [5, 6].
In macrophages, Nur77 is expressed in response to
proinflammatory stimuli like prostaglandins, tumor necro-
sis factor-α (TNFα), lipopolysaccharide (LPS), interferon
gamma (IFNγ) and granulocyte-macrophage colony
stimulating factor (GM-CSF) [7, 8]. There may exist some
discrepancy regarding Nur77’s anti-inflammatory role in
macrophage function [7–13]. To elucidate the role of
Nur77 in macrophages in more detail, we cultured
bone marrow-derived macrophages (BMM) from wild-
type (WT) and Nur77-deficient (Nur77-KO) mice,
stimulated the cells with LPS and employed, to our
knowledge for the first time, a gene expression study in
these cells. Our data support functional involvement of
Nur77 in (activated) macrophage physiology, by reveal-
ing the inhibition of stromal-derived factor (SDF)-1α
expression, regulation of Rac1-mediated phagocytosis,
extracellular matrix homeostasis and tolerance.
Results
Expression profiling reveals that Nur77 modulates
inflammatory gene expression in macrophages
To understand the function of Nur77 in macrophages,
RNA was isolated from BMM isolates derived from
Nur77-KO and WT mice and transcriptionally profiled.
In these cells 324 genes were differentially expressed in
Nur77-KO compared with WT BMM (p-value <0.05,
absolute fold change ≥1.4), of which 64 % were upregulated
and 36 % were downregulated in Nur77-KO compared with
WT BMM. The top 25 up- and downregulated genes are
shown in Fig. 1a and listed in Additional file 1: Table S1.
These data were verified by qRT-PCR (Additional file 2:
Figure S1) for S100 calcium binding protein A9 (S100A9),
Neuropeptide Y (NPY) and serine (or cysteine) peptidase
inhibitor G1 (Serping1) showing higher expression in
Nur77-KO BMM and for FBJ osteosarcoma oncogene
(cFos) showing decreased expression. We performed In-
genuity pathway downstream effects analysis to visualize
the effect of Nur77 deficiency on biological processes and
disease. Our microarray data imply enhanced inflammation
in Nur77-KO BMM as inflammatory response, cell-to-cell
signaling and interaction, hematological system develop-
ment, cellular movement and immune cell trafficking are
predicted to be activated in these cells compared to WT
BMM (Fig. 1b).
In BMM Nur77 reduces SDF-1α promoter activity
Previously, we have shown that SDF-1α, also known as
CXCL12, mRNA expression is increased in Nur77-KO
BMM, independent of stimulation and that overexpres-
sion of Nur77 in Nur77-KO BMM normalized SDF-1α
expression [10]. In the current study, SDF-1α was also
present in the top 25 of upregulated genes in Nur77-
deficient BMM (Fig. 1 and Table S1).
Nur77-KO BMM have been shown to exhibit a proin-
flammatory phenotype after LPS activation involving en-
hanced expression of multiple cytokines [10, 12]. For
many cytokines the enhanced expression in the absence
of Nur77 may be explained by the transrepressive inter-
action between Nur77 and p65 NFκB [5, 6]. Induction of
SDF-1α expression, however, involves activation of the
non-canonical p52 NFκB pathway [14, 15]. In order to
establish the mechanism by which Nur77 represses SDF-
1α, we investigated p52 activity, which turned out to be
similar in WT and Nur77-KO BMM upon LPS or CD40
activation. These data indicate that the difference in
SDF-1α expression due to Nur77 deficiency cannot be
explained by changes in the p52 NFκB signaling pathway
(Fig. 2a). Subsequently, we analyzed the sequence of the
SDF-1α promoter and found one potential NBRE
consensus sequence at position -160 bp in the SDF-1α
promoter region: ‘AAAGGTCT’ in which the last A resi-
due of the consensus sequence is missing (Fig. 2b). Two
promoter reporter constructs comprising bp −1023
to +18 and bp −500 to +18 were placed in luciferase
reporter plasmids and were tested for activity. The
shorter fragment drives higher basal luciferase expression
than the longer construct, which may be caused by in-
hibitory elements in the bp −500 to −1023 region of the
promoter. Overexpression of Nur77 resulted in strong
inhibition of both reporters. Furthermore, mutation of
the potential NBRE (AAAGAACT; dNBRE) reduced
this inhibitory activity of Nur77 4–5 fold (Fig. 2b).
These data are in line with the data obtained from ChIP
experiments revealing that Nur77 interacts with this
SDF-1α promoter region (Fig. 2c).
Nur77 enhances expression of CX3CR1 in BMM
One of the most strongly downregulated genes in
Nur77-KO BMM was CX3CR1, which is the receptor
for the cytokine CX3CL1, also known as fractalkine.
CX3CR1 is expressed on a subset of monocytes that in
mice are typically Ly6Clo. These monocytes are known
as patrolling monocytes with a crucial function in
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endothelial cell maintenance and are lacking in Nur77-
KO mice [16]. qPCR confirmed decreased CX3CR1
mRNA expression in Nur77-KO BMM compared to
WT cells (Fig. 3a). In line with this observation, Nur77
knockdown in WT BMM showed diminished CX3CR1
expression compared to shCON treated cells (Fig. 3a),
whereas Nur77 overexpression in RAW cells resulted
in increased CX3CR1 expression (Fig. 3b). Moreover,
CX3CR1 protein expression was attenuated in Nur77-
KO BMM compared to WT BMM (Fig. 3c). CX3CR1
deficiency in mice results in a decrease of lamina pro-
pria macrophages and increased severity of experimen-
tal colitis [17]. Since macrophage CX3CR1 plays such
an important role in gut tolerance, we also determined
its mRNA expression in mouse colon (Fig. 3d) and
observed a modest but significant reduction of CX3CR1
expression in Nur77-KO colon lysates, which may indi-
cate a decreased macrophage tolerance possibly making
Nur77-KO mice more prone to develop colitis. We
have recently investigated the function of Nur77 in
inflammatory bowel disease and have shown that defi-
ciency of Nur77 indeed aggravates both DSS- and
TNBS-induced colitis [18].
Modulation of extracellular matrix production in BMM by
Nur77
To obtain a better understanding of the functional
differences between WT and Nur77-KO macrophages,
we performed Ingenuity pathway analyses (IPA) to iden-
tify canonical pathways with a statistically significant en-
richment of differentially expressed genes. The top 25
canonical pathways discriminating WT from Nur77-KO
BMM are shown in Fig. 4a and details on the genes
regulated in those pathways are presented in Additional
file 1: Table S2. The top ranking canonical pathway is
‘Inhibition of matrix metalloproteinases’ (MMPs), which
comprises 36 genes, 11 of which show changed expression
in Nur77-KO BMM compared with WT cells. Interestingly,
13 of the top 25 canonical pathways involve regulation of
MMPs, their inhibitors the tissue inhibitor of metallopro-
teinases (TIMPs) and/or collagens (Additional file 1: Table
S2). Additionally, gene set enrichment analysis (GSEA) was
performed to identify Biocarta, KEGG, PID or Reactome
pathways that are regulated in Nur77-KO BMM compared
to WTcells. Of the top 20 enriched gene sets, 12 are related
to extracellular matrix interactions (Additional file 1: Table














































































































































































Fig. 1 Nur77 modulates inflammatory gene expression in macrophages. a Heatmap of the top 25 up- and downregulated genes in Nur77-KO
compared with WT BMM. The changes in mRNA abundance in Nur77-KO compared to WT BMM were determined by microarray analysis. The
color-coded scale (green indicates downregulation and red indicates upregulation) for the log2-transformed expression values, normalized per
gene, is indicated at the right of the figure. b Increased and decreased biological functions in Nu77-KO compared to WT BMM identified by IPA
downstream effects analysis. The color-coded scale at the left of the figure reflects the direction of change for the function, based on the
regulation z-score (orange indicates upregulation and blue indicates downregulation, white represents a z-score of zero and grey represents
not available). The size of the box reflects the p-values (large box, small p-value)
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genes encoding proteins belonging to MMP, TIMP or colla-
gen families was summarized in a Volcano plot (Fig. 4b),
revealing that MMP7 expression was reduced in Nur77-
KO BMM (0.6 fold, p = 0.04), whereas the expression of
MMP2 (2.4-fold, p = 0.08), MMP9 (1.6-fold, p = 0.09),
MMP14 (1.5-fold, p = 0.08), MMP23 (2.6-fold, p = 0.04),
TIMP2 (1.4-fold, p = 0.08) and TIMP3 (4-fold, p = 0.03)
was increased or showing a trend towards increased expres-
sion. MMPs and TIMPs are crucial regulators of extracellu-
lar matrix composition and macrophages have been shown
to produce collagens [19–21]. The expression of several
collagen subtypes (Col1a1, Col6a2 and Col12a1; 6-fold, 1.8-
fold and 3.3-fold, respectively; p < 0.05) was significantly
increased in Nur77-deficient BMM. Total MMP activity in
protein lysates from Nur77-KO and WT BMM was deter-
mined by zymography, and as shown in Fig. 4c, both under
control conditions as well as after LPS stimulation, espe-
cially MMP9 (92kD), was significantly lower in Nur77-KO
BMM compared to WT cells. The balance between MMP-
and TIMP activity and collagen synthesis eventually deter-
mines the net collagen content of the extracellular matrix.
Because each of these aspects was changed in Nur77-KO
BMM, the collagen content of BMM was subsequently
measured and was significantly higher in Nur77-KO BMM
both before and after LPS stimulation (Fig. 4d) compared
to WT BMM. These data clearly reveal involvement of
Nur77 in extracellular matrix composition, unexpect-
edly indicating that Nur77 reduces collagen content of
BMM matrix.
Disease pathways
To link gene sets that are upregulated in Nur77-KO
BMM compared to WT cells with human disease path-
ways, we performed GSEA (Table 1). Several of these
diseases are already known to be associated with Nur77,
namely vascular disease (carotid artery disease and coron-
ary disease), cancer (hematologic neoplasms, hepatocellular
carcinoma), metabolism (glucose intolerance and diabetic
nephropathies, angiopathies and retinopathy) and kidney
ischemia reperfusion injury [10, 22–28]. Westbrook et al.
[29] have shown that Nur77-deficient rats on a kidney
injury-susceptible genetic background exhibited decreased
renal function and attenuated kidney injury, which was res-
cued by bone marrow transplanted from control animals,
suggesting a strong immune cell or even macrophage medi-
ation. Furthermore, proteinuria was reported in Nur77-KO
rats, which correlates with the current GSEA analysis pre-
dicting proteinuria. However, we did not find a difference
in urine total protein or albumin levels between healthy
WT and Nur77-KO mice, which of course may be different
in kidney disease models (data not shown). In addition, our
GSEA indicated that Nur77 may functionally be involved in
systemic scleroderma; this is characterized by thickening of







































































































































































Fig. 2 Nur77 represses SDF-1α expression through binding to an
NBRE in the SDF-1α promoter. a The activation of the non-canonical
NFκB pathway was measured in Nur77-KO and WT BMM by determining
active p52 levels in the presence of LPS or CD40 activating antibody.
b Analysis of the SDF-1α promoter region revealed the presence of an
NBRE. Mutation analysis showed involvement of this NBRE in
Nur77-dependent repression of SDF1α expression as measured by
luciferase activity. Data were normalized for transfection efficiency
by corresponding Renilla luciferase activity and in the right panel
are depicted relative to the luciferase activity in the absence of
Nur77. dNBRE, mutation of NBRE. c Nur77 binding to the SDF-1α
promoter was determined by ChIP analyses using SDF-1α promoter-
specific primers and Nur77-specific antibodies (M210) or control IgG in
BMM after lentiviral overexpression of Nur77. Data are representative of
at least three independent experiments performed in triplicate. Values
represent mean ± S.D. *p< 0.05, **p< 0.01
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et al. have recently shown that loss of Nur77 exacerbates
fibrosis in multiple models of skin fibrosis [30], which is in
line with the increased collagen production we observed in
Nur77-KO BMM. GSEA indicated that Nur77 may also
functionally be involved with macular degeneration,
chronic obstructive pulmonary disease and osteoarth-
ritis. The latter corresponds with the IPA revealing
several rheumatoid arthritis signaling pathways to be
effected (Fig. 4a and Additional file 1: Table S2).
Upstream regulators
IPA Upstream Regulator Analysis was used to identify
proteins that may be responsible for gene expression
changes observed in our dataset. IPA predicts which up-
stream regulators are activated or inhibited to explain
the upregulated and downregulated genes observed in
the dataset. Knowledge of this regulatory cascade may
indicate novel pathways that elucidate (part of ) the
observed gene expression changes in our dataset. IPA
upstream regulator analysis identified 22 upstream regu-
lators that are activated in Nur77-KO BMM and nine
inhibited factors, among which Nur77 (NR4A1). Six of
the upstream regulators, besides Nur77 itself, have been
described to interact with Nur77; NOR1, SMARCA2,
SMARCA4, TP53, HIF-1α, and β-catenin (CTNNB1),
resulting in altered signaling [31] (Additional file 1:
Table S4, Fig. 5a). In addition to transcription factors,
also kinases and enzymes are among the predicted
upstream regulators. Our analysis revealed Rac1 as an
activated upstream regulator possibly regulating Nur77-
mediated changes in gene expression. We therefore mea-
sured the levels of active Rac1 in Nur77-KO and WT
BMM and observed that only Nur77-KO BMM contain
active Rac1, which is completely inhibited by Rac1 inhibi-
tor, whereas WT BMM show no basal Rac1 activity
(Fig. 5b), indicating that Nur77 is involved in a negative
feedback loop with Rac1. Since Rac1 is highly involved in
cell motility and cytoskeleton movements in phagocytosis
[32–34], we subsequently tested the Fcγ receptor-
mediated phagocytosis capacity of Nur77-KO and WT
BMM. As is shown in Fig. 5c, the phagocytosis index of
Nur77-KO BMM regarding uropathogenic E. coli was
almost 2-fold higher compared to WT cells. In addition to
being involved in phagocytosis, Rac1 is known to inhibit
MMP9 expression [35] correlating with our findings that





























































































Fig. 3 CX3CR1 is downregulated in Nur77-KO BMM and its expression is reduced in colons of Nur77-KO mice. mRNA expression of CX3CR1
was determined by qRT-PCR after treatment with 100 ng/ml LPS for the indicated time points in (a) WT and Nur77-KO BMM and in WT
BMM transduced with control (shCON) or Nur77 (shNur77) shRNA and (b) in RAW cells transfected with control (Mock) or Nur77-encoding
plasmids. c CX3CR1 protein expression in WT and Nur77-KO BMM after stimulation with 100 ng/ml LPS for 0 h (c) or 24 h. Protein expression was
normalized to β-actin expression for quantification. d mRNA expression of CX3CR1 in colons of WT and Nur77-KO mice was determined by qRT-PCR.
Data are expressed as mean ± S.D. *p < 0.05, **p < 0.01, ***p < 0.001
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Discussion
In the current study we performed a transcriptome
analysis to explore the function of Nur77 in macrophage
function in addition to its known role in modulation of
inflammatory responses [10, 12]. The obtained data uncov-
ered involvement of Nur77 in extracellular matrix modula-
tion, macrophage tolerance and inhibition of phagocytosis
(schematically summarized in Fig. 6) and insight in its
potential function in several diseases.
In line with our previous observations, CXCL12/SDF-1α
expression was higher in Nur77-KO BMM than in WT
cells. Even though Nur77 transrepresses NFκB p65, Nur77
did not affect NFκB p52 activity. Rather, direct binding of





















































































































































































































































































































































































































































































































































































Fig. 4 Nur77 deficiency results in decreased MMP activity and enhanced collagen content. a The top 25 canonical pathways associated with differentially
expressed genes comparing Nur77-KO with WT BMMs were identified by IPA. The line graph represents the ratio of differentially expressed genes from the
dataset to the genes present in each canonical pathway. The pathways are ranked from highest to lowest degree of association between genes from the
data set with the pathways by the p-value, calculated by a right tailed Fisher Exact Test. The bar graph represents the -log(p-value) and the
threshold represents p = 0.05. b The -log10 p-values of the MMPs (blue), TIMPs (red) and collagens (green) were plotted against their corresponding
log2 fold changes (Nur77-KO vs WT) in unstimulated (left panel) and LPS stimulated (right panel) BMM. c MMP activity in BMM lysates derived from WT
and Nur77-KO mice was determined by zymography and MMP9 activity was quantified (right panel). c, control; LPS, 24 h stimulation with 100 ng/ml
LPS. d Collagen content measured in WT and Nur77-KO BMM stimulated for 24 h with 100 ng/ml LPS. *p < 0.05, **p < 0.01, ***p < 0.001
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to inhibit expression of this gene. It was unexpected to
detect diminished MMP9 activity, increased TIMP1-3
gene expression and enhanced expression of several colla-
gen subtypes, among which Col1a1, present in the list of
top-25 regulated genes, Col6a1 and Col12a1. Of note,
Wang et al. [36] recently demonstrated that Nur77 aug-
ments MMP9 expression in colorectal cancer cells pro-
moting invasion and metastasis of colorectal cancer.
Corresponding with these observations, Nur77-KO BMM
were shown to synthesize more collagen in their subcellu-
lar matrix compared to WT macrophages. This aspect of
macrophages is relevant to wound healing, however,
wound closure is normal in Nur77-KO mice [37]. Wound
healing is a complex process involving multiple cell types,
which may explain why overexpression of a dominant-
negative variant of Nur77 in endothelial cells disturbs
normal wound healing. In a similar way, Nur77 may need
to be studied in more detail in macrophages during
wound healing.
The most strongly downregulated gene in the absence
of Nur77 was CX3CR1, which is especially expressed on
colon lamina propria macrophages that sample antigen
from the intestinal lumen [38]. CX3CR1high macro-
phages produce IL-10, contributing to the maintenance
and local expansion of protective regulatory T cells in
the gut [39]. CX3CR1 expression was not only decreased
in Nur77-KO BMM, but also in colon samples of these
mice compared to WT colon. Previously, we have shown
that IL-10 production by Nur77-KO BMM is lower
compared to WT BMM [10]. Together, these data indi-
cate a role for Nur77 in macrophage tolerance towards
host bacteria in the gut and recently we have shown that
dysregulation of Nur77 expression indeed leads to en-
hanced development of inflammatory bowel disease [18].
In the IPA upstream regulator analysis, we found the
small GTPase Rac1 as an intriguing, unknown regulator
of Nur77-mediated gene expression, which by itself is
regulated by Nur77-deficiency. Rac1 is critically involved
in cytoskeletal rearrangements [40, 41] and thus import-
ant in cell motility. In macrophages, it predominantly
regulates Fcγ receptor-mediated phagocytosis [33, 34],
cell fusion [42] and migration [43]. We found increased
Rac1 activity upon Nur77 deficiency in BMM and a
drastic increase in phagocytic capacity of Nur77-KO
BMM in an E.coli opsonization model. These data
strongly support our previous finding that Nur77-KO
mice show a better initial clearance of bacteria during
E.coli-induced peritonitis [11]. The latter study showed
Table 1 Top 20 human disease pathway gene sets identified with GSEA that are upregulated in Nur77-KO vs WT BMM
Human disease pathways NES p-value Adjusted p-value Molecules contributing to the pathway
Birth weight 2.060 0.002 0.007 NPY,H19,SERPINH1,GHR,IGF2
Diabetes mellitus type 1 1.993 <0.001 0.015 NPY,CXCL12,DCN,HP,CALD1,IGF2,TAF5L, RAGE,VWF,
CBLB,ENPP1,VEGFA,AGER,VDR, SOD3
Proteinuria 1.856 <0.001 0.090 NPY,DCN,HP,ADM,RAGE,ENPP1,VEGFA,AGER
Diabetic nephropathies 1.854 0.002 0.068 DCN,HP,CCL5,MPO,CALD1,MMP9,ADM,RAGE,VWF,ENPP1,
VEGFA,AGER,APOE
Pulmonary disease, chronic obstructive 1.852 0.007 0.057 COL1A1,MPO,SERPINE2,MMP9,GSTM1,TIMP2,VDR, SOD3
Carotid artery diseases 1.840 0.003 0.054 NPY,CXCL12,MMP3,MMP9
Coronary disease 1.826 0.003 0.058 NPY,PDGFRA,VLDLR,HP,COL3A1,MMP2, CDKN2B,CDKN2A,
F7,MMP3,MMP9,F2R, HMGCR,VWF,ENPP1,VEGFA,APOE,VDR,
LDLR,ESR1,SCARB1
Macular degeneration 1.818 <0.001 0.056 C2,HTRA1,MMP9,VEGFA,APOE,ERCC6
Fracture bone 1.804 0.004 0.058 COL1A1,COL1A2,TNFRSF11B,MMP9
Diabetic angiopathies 1.798 0.007 0.056 NPY,HP,F7,VWF,VEGFA,AGER
Diabetic retinopathy 1.791 0.009 0.055 NPY,RAGE,VEGFA,AGER
Scleroderma systemic 1.789 0.012 0.052 SPARC,FBN1,COL1A2,CCL5,FN1,IL1A
Glucose intolerance 1.789 0.011 0.048 NPY,GHR
Carcinoma ductal breast 1.788 0.005 0.045 MMP2,MMP9,ATM,VEGFA
Osteoarthritis 1.766 0.004 0.055 COL1A1,WISP1,MMP2,ENPP1,VDR,COL2A1
Carcinoma hepatocellular 1.736 0.011 0.072 HP,TFRC,F7,IGF2,HMGCR,APC,GSTM1
Osteoporosis, postmenopausal 1.724 0.012 0.078 COL1A1,TNFRSF11B,PLXNA2,VDR,ESR1, CALCA
Hematologic neoplasms 1.683 0.021 0.116 CXCL12,HPSE,GSTM1
Cognition disorders 1.678 0.019 0.117 VLDLR,MPO,BCHE,HMGCR,APOE,PRNP,DRD4, DTNBP1,CPOX
Angina, unstable 1.672 0.017 0.118 COL3A1,F7,MMP3,TAF1
NES Normalized enrichment score
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that the responsiveness of peritoneal macrophages to E.
coli was only mildly affected by Nur77-deficiency,
which is in line with our microarray data that reveal a
limited effect of Nur77-deficiency on LPS-induced
changes in gene expression (Additional file 1: Tables S5
and S6).
Our unbiased analyses of signaling pathways and dis-
eases resulted in multiple hits relating to vascular dis-
ease and atherosclerosis. More specifically, gene sets
identified with GSEA are; ‘Signaling by PDGF, Smooth
muscle cell contractions, Sphingolipid metabolism and
CXCR4 pathway’ [44–46] (Additional file 1: Table S3). In
addition, GSEA revealed ‘carotid artery diseases’ and
‘coronary disease’ in the top 20 of human disease path-
ways, whereas ‘atherosclerosis signaling’ was found in
IPA amongst the top 25 of canonical pathways associ-
ated with differentially expressed genes in Nur77-KO
versus WT BMM (Fig. 4 and Additional file 1: Table S2).
Altogether, the analyses on BMM gene expression sup-
port the protective function of Nur77 in atherosclerosis
[10, 12, 24]. The other two members of the same sub-
















































# regulators known to interact with Nur77 






































0 1 2 3 4
0 2 4 6 8 10
Fig. 5 Rac1 is an upstream regulator activated in Nur77-KO BMM resulting in enhanced phagocytosis in these cells. a Upstream regulators in
Nur77-KO compared to WT BMM identified by IPA upstream regulator analysis. The bias-corrected z-score and the p-value were calculated as
described in Additional file 1: Table S4. b Active Rac1 levels were determined in the presence and absence of the Rac1 inhibitor 553502. c Phagocytosis of
FITC-labeled uropathogenic E. coli bacteria by WT and Nur77-KO BMM was measured by flow cytometry and the phagocytosis index was calculated as the













Less attraction of inflammatory cells
TIMP mRNA
Fig. 6 Role of Nur77 in macrophages. Nur77 modulates the
inflammatory state of macrophages through multiple mechanisms,
decreases collagen production by lowering TIMP1-3 and collagen
mRNA expression, and lowers Rac1 activity resulting in decreased
phagocytosis capacity. Green indicates a protective effect and red
depicts a negative effect of Nur77 expression
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are also expressed in human atherosclerotic lesion
macrophages and were shown to repress LPS-induced
inflammatory response in THP-1 macrophages [7]. Simi-
larly as Nur77, transplantation of bone marrow deficient
for NOR-1 into atherosclerotic mice, aggravates the
formation of atherosclerotic lesions [47].
Even though our gene expression analyses were
performed in macrophages, a potential involvement of
Nur77 in ‘diabetic nephropathy, angiopathy and retin-
opathy and glucose intolerance’ was predicted from
GSEA (Table 1), which may emphasize the relative
importance of macrophages in these pathologies.
Macrophages are indeed known to contribute to the ne-
phropathies [48–52], angiopathies [53, 54] and retinopathy
[55, 56] seen in diabetes. Nur77 regulates hepatic glucose
homeostasis [57] and Nur77-deficiency causes increased
diet-induced insulin resistance [23]. Regarding the recent
observation that lipid storage by adipose tissue macro-
phages regulates systemic glucose tolerance [58], it may be
interesting to investigate glucose tolerance after a Nur77-
deficient bone marrow transplantation into Ob/Ob mice.
Finally, we found multiple, often chronic inflammatory
diseases to be potentially influenced by macrophage Nur77
expression. In most of these diseases macrophages are
known to play a role. GSEA (Table 1) revealed osteoarth-
ritis, chronic obstructive pulmonary disease and macular
degeneration, whereas IPA (Additional file 1: Table S2)
associated Nur77 to rheumatoid arthritis, psoriasis and
allergic airway inflammatory diseases. Interestingly, recently
Kurakula et al. [59] showed a protective role for Nur77 in
ovalbumin-induced airway inflammation. Nur77 expression
is elevated in synovial tissue, cartilage and prostaglandin E2
(PGE2) stimulated chondrocytes from patients with
rheumatoid arthritis, psoriatic arthritis or osteoarth-
ritis, making Nur77 an attractive target in rheumatic
diseases [60–63]. In addition, T cell-specific Nur77
overexpression results in reduction of incidence and
severity of collagen-induced arthritis by promoting
activation-induced T cell apoptosis and inhibition of
CollagenII-specific antibody production [64]. Interest-
ingly, Nurr1 has already been shown to modulate
psoriasis and rheumatoid arthritis [60, 61, 65]. The
observed associations reveal potential, and so far
speculative, connections between Nur77 and rheuma-
toid arthritis, macular degeneration, psoriasis and
chronic obstructive pulmonary disease and we there-
fore propose that it may be relevant to study the role
of Nur77 in these diseases.
Conclusions
Our transcriptome analysis to explore the role of Nur77
in macrophage function uncovered involvement of
Nur77 in extracellular matrix modulation, macrophage
tolerance and inhibition of phagocytosis and insight in
its potential function in several diseases. In summary, as
schematically shown in Fig. 6, Nur77 modulates the
inflammatory state of macrophages by decreasing inflam-
matory gene expression in macrophages via NFκB transre-
pression and positively regulating CX3CR1 expression.
Nur77 directly represses SDF-1α secretion, which may re-
sult in less chemo-attraction of inflammatory cells. In
addition, Nur77 inhibits the collagen content of the extra-
cellular matrix of macrophages, diminishes Rac1 activity
and reduces phagocytosis of these cells. All these effects
can influence a plethora of inflammatory and metabolic
diseases, making Nur77 an interesting factor to study and




Nur77-KO mice [66] on a C57BL/6 background were
kindly provided by Prof B.R. Binder (Vienna, Austria).
All animal experiments were approved by the Committee
for Animal Welfare of the Amsterdam Medical Center
and were carried out in compliance with guidelines issued
by the Dutch government.
Macrophage cell culture and transfection
Each batch of bone marrow cells was isolated from
femurs and tibiae of three wild-type (WT) mice and
three Nur77-KO mice as described [10]. In brief, cells
were cultured in RPMI-1640 (GIBCO Invitrogen) with
100 U/ml penicillin/streptomycin (GIBCO Invitrogen),
10 % heat-inactivated fetal calf serum (FCS; GIBCO Invi-
trogen) and 15 % L929 conditioned medium (LCM) for
8 days to generate BMM. BMM were seeded at a density
of 1.5 × 105 cells/cm2 24 h before stimulation. In WT
BMM Nur77 was knocked-down by lentiviral transduc-
tion with a short hairpin (sh-)Nur77 cloned into a
p156RRL-sinPPT-CMV-GFP-PRE/NheI vector by Bonta
et al. [7] Lentiviral particles were produced as described
previously [7] and BMM were transduced for 24 h with
recombinant lentivirus. After transduction, cells were
cultured for another 24 h and thereafter stimulated with
100 ng/ml LPS. shCON lentivirus was taken along as a
control. Knockdown was confirmed by qPCR.
RAW264.7 cells were cultured in RPMI-1640 supple-
mented with 10 % FCS and penicillin/streptomycin and
were transfected using Lipofectamine LTX (all Invitro-
gen) according to the manufacturer’s instructions.
Microarray profiling
RNA was isolated from Nur77-KO and WT BMM using
the Aurum total RNA isolation kit (BioRad) and samples
were sent to ServiceXS (Leiden, The Netherlands) for
further microarray processing. In brief, to assess the
quality of the samples, the concentration of the RNA
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was determined using the Nanodrop ND1000 spectropho-
tometer. The Agilent Bioanalyzer was used to analyze the
quality and integrity of the RNA samples. The Illumina
TotalPrep-96 RNA Amplification Kit was used to generate
biotin labeled (biotin-16-UTP) amplified cRNA and the
obtained biotinylated cRNA samples were hybridized onto
the Illumina MouseWG-6 v2 arrays. The samples were
scanned using the Illumina iScan array scanner and
the data retrieved using Illumina’s Genomestudio v.
2011.1 software.
Microarray pre-processing and data analysis
Analyses were carried out with Bioconductor packages
in the statistical software package R (version 2.14.0).
Normexp-by-control background correction, quantile
normalization, and log2 transformation [67] were per-
formed on the Illumina sample and control probe pro-
files using the limma package (version 3.10.2). The
arrayQualityMetrics package (version 3.10.0) was used
to assess whether the microarray data were of good
quality. Only probes detected (detection p-value < 0.05)
on at least one array were included in the differential
expression analysis. Gene-wise linear models were fitted
using the limma package. Differential expression between
the different conditions was assessed via a moderated t-test.
The illuminaMousev2.db package (version 1.12.2) was used
to update the probe annotation provided by Illumina. The
data set with differentially expressed genes (nominal
p-value < 0.05) was analyzed using Ingenuity Pathway
Analysis (IPA, Ingenuity Systems) to test for enriched
canonical pathways, to identify biological functions that
are expected to be affected and to identify upstream tran-
scriptional regulators. The background set for the gene
enrichment analyses consisted of all genes that were de-
tected on at least one array. Significance of enrichment
was calculated using a right-tailed Fisher’s Exact Test.
Gene set enrichment analysis (GSEA; version 2.2.0
[68],) was performed using default options except for the
following: the permutation type =Geneset; and the number
of permutations = 1000 [69, 70]. The gene set collection
c2.cp.v5.0.symbols.gmt which includes canonical pathways
was queried in this analysis. The gene set to query human
diseases was derived from [71] and GSEA was performed
as described above except that the minimum number of
genes in a gene set was set at 4.
Plasmids
A construct containing amino-terminally myc-tagged
Nur77 has been described before [3]. Two fragments of
the murine SDF-1α promoter containing a putative
NBRE (from −500 to +18 bp and from −1023 to +18 bp
relative to the transcriptional start site) were cloned into
the pGL3 basic vector (Promega) in front of the firefly
luciferase gene. The mutant of the promoter constructs
in which the putative NBRE was disrupted was generated
by site-directed mutagenesis using the QuickChange site-
directed mutagenesis method (Stratagene) according to
the manufacturer's instruction using the following primer:
dNBRE forw: 5’-ctgggaagatcaaagAActcagcacccagcgg-3’
and dNBRE rev: 5’-ccgctgggtgctgagTTctttgatcttcccag-3’.
The nucleotides in capital letters represent the mutated
nucleotides in the SDF-1α promoter. The construct was
verified by sequencing and did not contain any other se-
quence variations.
NFκB p52 activation/binding
BMM were stimulated with either 100 ng/ml LPS for 1 h
or 25 μg/ml CD40 activating antibody FGK45 (Bioceros
BV) for 3 h, protein lysates were harvested and the levels
of active p52 were determined using the TransAM NFκB
family kit (Active Motif) according to the manufacturer’s
protocol. The absorbance was measured at OD450 nm in
a microplate reader (EL808, Bio-Tek instruments).
Luciferase reporter assays
RAW264.7 cells were transiently transfected with wild-
type or mutant SDF-1α luciferase reporter plasmids to-
gether with pCMV-Myc-Nur77 or pCMV-mock. pRL-TK
Renilla reporter plasmid (Promega) was co-transfected as
an internal control. Luciferase activity measurements were
performed using the dual-luciferase reporter assay system
(Promega) and Glomax Multi detection system (Promega)
according to the manufacturer’s instructions. Each experi-
ment (in duplicate) was repeated at least three times.
Chromatin immunoprecipitation assay (ChIP)
BMM were infected with Mock- or Nur77-adenovirus at
a MOI of 100 for 4 h, and 28 h after infection the cells
were harvested for ChIP analysis. ChIP assays were per-
formed using the Magnify ChIP system (Invitrogen) accord-
ing to the manufacturer’s instructions. The following
primers were used to amplify the SDF-1α promoter in
semi-quantitative real-time (qRT)PCR: 5’-GACTGTTTCG
TCTCTCAGGTTC-3’ (sense) and 5’-GCTGAGACCTTT
GATCTTCCCA-3’ (antisense).
qRT-PCR
Total RNA was extracted using the Aurum™ Total RNA
Mini Kit (Biorad) and cDNA was made from 500 ng RNA
using iScript cDNA Synthesis kit (BioRad). qRT-PCR was
performed using iQ SYBR Green Supermix (BioRad) and
was measured using the MyIQ system and the following
primers: Cx3cr1 forw: 5’-gagtatgacgattctgctgagg-3’ and
Cx3cr1 rev: 5’-cagaccgaacgtgaagacgag-3’. Ribosomal pro-
tein 36B4 expression was determined to correct for cDNA
content (36B4 forw: 5’-ggacccgagaagacctcctt-3’, 36B4 rev:
5’-gcacatcactcagaatttcaatgg-3’).
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Western blot analysis
BMM were treated for 24 h with 100 ng/ml LPS, after
which the cells were washed twice with PBS and lysed in
ice-cold Nonidet P-40 (NP-40) lysis buffer (50 mM Tris–
HCl pH7.4, 100 mM NaCl, 10 mM NaF, 1 mM Na3PO4,
10 % glycerol, 1 % NP-40). After a 10 min incubation on ice
the lysates were collected and boiled in sample buffer
containing DTT. Samples were thereafter analyzed by SDS-
PAGE. All proteins of interest were separated on 12 % poly-
acrylamide SDS gels. Proteins were transferred to 0.2 μm
nitrocellulose membranes using the Trans-blot Turbo
transfer system (Biorad). Nitrocellulose membranes were
subsequently blocked in 5 % (w/v) non-fat milk in Tris-
buffered saline (TBS) and incubated with CX3CR1 (Santa
Cruz) and anti-α-tubulin (Cedarlane) primary antibodies
overnight at 4 °C, followed by horse radish peroxidase-
labelled secondary antibodies (Bio-Rad) for 1 h. Proteins
were visualized with an enhanced chemiluminescence
(ECL) detection system (Thermoscientific) and quantifica-
tion of signal was performed using intensity measurements
in ImageJ software.
Collagen content assay
Collagen content of WT and Nur77-KO BMM was mea-
sured as described before [72]. Briefly, BMM were
seeded at a density of 2 × 105 cells/well in 24-wells
plates. Cells were rinsed with PBS and fixed with 4 %
para-formaldehyde and collagen content was stained by
incubating with a 0.1 % (w/v) solution of Sirius Red F3B
dye (BDH Laboratory Supplies) in 10 mM HCl for
40 min. Unbound dye was removed by washing exten-
sively with 10 mM HCl, after which 100 mM NaOH was
added to dissolve the dye and the absorbance was mea-
sured at OD550 nm in a microplate reader (EL808, Bio-
Tek instruments).
Zymography
Gelatinolytic metalloproteinase activity, especially MMP2
and MMP9, in WTand Nur77-KO BMM was measured by
separating lysates of these cells on 10 % polyacrylamide gels
containing gelatin (Ready-Gel zymogram gels, BioRad)
under non-reducing conditions. After electrophoresis, the
proteins were renatured by placing the gels in 2.5 % Triton
X-100 for 30 min at room temperature and developed over-
night in developing solution (50 mM Tris–HCl, pH 7.5,
200 mM NaCl, 5 mM CaCl2, 0.02 % Brij-35), followed by
staining with PageBlue Protein Staining Solution (Thermo
Scientific). After destaining with MilliQ, gelatinase activity
was measured by densitometry.
Rac1 activity assay
WT and Nur77-KO BMM were treated for 16 h with Rac1
inhibitor (553502; Calbiochem) followed by a 24-h incuba-
tion with 50 ng/ml interferon-γ (IFNγ, Peprotech). Cell
lysates were prepared and the levels of Rac1-GTP were
measured using a colorimetric-based G-LISA Rac1 (BK128;
Cytoskeleton) activation assay according to the manufac-
turer’s protocol. OD490 nm was measured with a micro-
plate reader (EL808, Bio-Tek instruments). Absorbance
units in each sample were expressed after subtraction of
the background units measured in protein-free lysis buffer.
Phagocytosis
BMM were cultured overnight at 37 °C in RPMI containing
10 % FCS at a density of 0.5x106 cells/well in 12-wells
plates. BMM were washed twice with Hanks' balanced salt
solution (GIBCO/Invitrogen) prior to the addition of fluo-
rescently labeled bacteria. Uropathogenic E. coli (strain
1677) [73] were heat-killed by incubation at 65 °C for 1 h
and labeled with 0.2 mg of FITC (Sigma-Aldrich) per ml in
0.1 M NaHCO3 (pH 9.0) for 1 h at 37 °C. The FITC-labeled
E. coli (equivalent to 50 × 106 CFU) were added to the
BMM at a ratio of 100:1 and incubated for 1 h at 37 °C or
4 °C. Phagocytosis was stopped by immediately transferring
the cells to 4 °C and washing them with ice-cold PBS con-
taining 2 mM EDTA. The cells were harvested by gentle
scraping and were subsequently treated with 0.4 % Trypan
blue (GIBCO/Invitrogen) to quench extracellular fluores-
cence, washed twice with PBS/EDTA, and analyzed using a
flow cytometer (Becton Dickinson FACScalibur). Results
were expressed as phagocytosis index, defined as the per-
centage of cells with internalized E. coli times the mean
fluorescence intensity.
Statistical analysis
Data are reported as mean ± S.D. and were analyzed with
the unpaired Student’s t test. Values of p < 0.05 were con-
sidered statistically significant (*p < 0.05, **p < 0.01, ***p <
0.001 in the figures).
Availability of supporting data
The microarray data have been deposited in NCBI Gene
Expression Omnibus in a MIAME compliant format and
are accessible under GEO Series accession number
GSE68167.
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